Company Overview of NEXTherapeutics, Inc.
NEXTherapeutics Inc. researches and develops antibody immunotherapy and diagnostic drugs for the treatment of oncology, hematology, infection, and inflammation diseases. The company’s products include NXT 211, a radio labeled antibody for treating refractory Hodgkin's disease; and Anti-Ferritin antibody coupled with Isotope 111 Indium for detecting cancerous tissue and treating cancer diseases. The company was incorporated in 2000 and is based in Cambridge, Massachusetts.
Riverside Technology Center
840 Memorial Drive
Cambridge, MA 02139
Founded in 2000
Key Executives for NEXTherapeutics, Inc.
Similar Private Companies By Industry
|Alitair Pharmaceuticals, Inc.||United States|
|Puronyx, Inc.||United States|
|Asphelia Pharmaceuticals, Inc.||United States|
|Limerick BioPharma, Inc.||United States|
|Valeritas, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NEXTherapeutics, Inc., please visit www.nextherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.